New

Uric Acid Drug Market

2021

Uric Acid Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug Class (Antihyperuricemic Agents (Urate-Lowering Drugs), Non-steroidal Anti-inflammatory Drugs (NSAIDs, Corticosteroids, Colchicine, Other Drug Classes); Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies)

| Report Code: TIPRE00012954 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Uric Acid Drug Market 2028 by Drug Class, Non-steroidal Anti-inflammatory Drugs, Distribution Channel | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Uric acid is a chemical created when the body breaks down substances called purines. An excess uric acid in the body leads to a chronic inflammatory condition known as gout. An excess of uric acid leads to the formation of crystals in the body, which eventually leads to the deposition of uric acid crystals in joints, resulting in inflammation and pain.

MARKET DYNAMICS

The uric acid drug market is driving due to rise in the incidence and prevalence of gout and other related disorders, increased research and development expenditure, and growing awareness among people are projected to boost the global uric acid drugs market in the coming years. Moreover, due to the entry of new drug therapies such as Uloric, Krystexxa, Colcrys, and Adenuric the market is expected to offer lucrative opportunities during the forecast period.

MARKET SCOPE

The "Uric Acid Drug Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of uric acid drug market with detailed market segmentation by drug class and distribution channel. The uric acid drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in uric acid drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The uric acid drug market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as antihyperuricemic agents (urate-lowering drugs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, colchicine and other drug classes. On the basis of distribution channel, the market is categorized as online pharmacies, retail pharmacies, and hospital pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the uric acid drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The uric acid drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting uric acid drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the uric acid drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the uric acid drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from uric acid drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for uric acid drug in the global market. Below mentioned is the list of few companies engaged in the uric acid drug market.
The report also includes the profiles of key players in uric acid drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AstraZeneca plc.
  •  Boehringer Ingelheim GmbH
  •  Teijin Pharma Ltd.
  •  Regeneron Pharmaceuticals
  •  GlaxoSmithKline plc.
  •  Merck & Co. Inc.
  •  Novartis AG
  •  Savient Pharmaceuticals
  •  Mylan NV
  •  Horizon Therapeutics plc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Uric Acid Drug Market - By Drug Class
1.3.2 Uric Acid Drug Market - By Distribution Channel
1.3.3 Uric Acid Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. URIC ACID DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. URIC ACID DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. URIC ACID DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. URIC ACID DRUG - GLOBAL MARKET OVERVIEW
6.2. URIC ACID DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. URIC ACID DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIHYPERURICEMIC AGENTS (URATE-LOWERING DRUGS)
7.3.1. Overview
7.3.2. Antihyperuricemic Agents (Urate-Lowering Drugs) Market Forecast and Analysis
7.4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS
7.4.1. Overview
7.4.2. Non-steroidal Anti-inflammatory Drugs (NSAIDs Market Forecast and Analysis
7.5. CORTICOSTEROIDS
7.5.1. Overview
7.5.2. Corticosteroids Market Forecast and Analysis
7.6. COLCHICINE
7.6.1. Overview
7.6.2. Colchicine Market Forecast and Analysis
7.7. OTHER DRUG CLASSES
7.7.1. Overview
7.7.2. Other Drug Classes Market Forecast and Analysis
8. URIC ACID DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. ONLINE PHARMACIES
8.3.1. Overview
8.3.2. Online Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. HOSPITAL PHARMACIES.
8.5.1. Overview
8.5.2. Hospital Pharmacies. Market Forecast and Analysis
9. URIC ACID DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Uric Acid Drug Market Overview
9.1.2 North America Uric Acid Drug Market Forecasts and Analysis
9.1.3 North America Uric Acid Drug Market Forecasts and Analysis - By Drug Class
9.1.4 North America Uric Acid Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Uric Acid Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Uric Acid Drug Market
9.1.5.1.1 United States Uric Acid Drug Market by Drug Class
9.1.5.1.2 United States Uric Acid Drug Market by Distribution Channel
9.1.5.2 Canada Uric Acid Drug Market
9.1.5.2.1 Canada Uric Acid Drug Market by Drug Class
9.1.5.2.2 Canada Uric Acid Drug Market by Distribution Channel
9.1.5.3 Mexico Uric Acid Drug Market
9.1.5.3.1 Mexico Uric Acid Drug Market by Drug Class
9.1.5.3.2 Mexico Uric Acid Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Uric Acid Drug Market Overview
9.2.2 Europe Uric Acid Drug Market Forecasts and Analysis
9.2.3 Europe Uric Acid Drug Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Uric Acid Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Uric Acid Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Uric Acid Drug Market
9.2.5.1.1 Germany Uric Acid Drug Market by Drug Class
9.2.5.1.2 Germany Uric Acid Drug Market by Distribution Channel
9.2.5.2 France Uric Acid Drug Market
9.2.5.2.1 France Uric Acid Drug Market by Drug Class
9.2.5.2.2 France Uric Acid Drug Market by Distribution Channel
9.2.5.3 Italy Uric Acid Drug Market
9.2.5.3.1 Italy Uric Acid Drug Market by Drug Class
9.2.5.3.2 Italy Uric Acid Drug Market by Distribution Channel
9.2.5.4 Spain Uric Acid Drug Market
9.2.5.4.1 Spain Uric Acid Drug Market by Drug Class
9.2.5.4.2 Spain Uric Acid Drug Market by Distribution Channel
9.2.5.5 United Kingdom Uric Acid Drug Market
9.2.5.5.1 United Kingdom Uric Acid Drug Market by Drug Class
9.2.5.5.2 United Kingdom Uric Acid Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Uric Acid Drug Market Overview
9.3.2 Asia-Pacific Uric Acid Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Uric Acid Drug Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Uric Acid Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Uric Acid Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Uric Acid Drug Market
9.3.5.1.1 Australia Uric Acid Drug Market by Drug Class
9.3.5.1.2 Australia Uric Acid Drug Market by Distribution Channel
9.3.5.2 China Uric Acid Drug Market
9.3.5.2.1 China Uric Acid Drug Market by Drug Class
9.3.5.2.2 China Uric Acid Drug Market by Distribution Channel
9.3.5.3 India Uric Acid Drug Market
9.3.5.3.1 India Uric Acid Drug Market by Drug Class
9.3.5.3.2 India Uric Acid Drug Market by Distribution Channel
9.3.5.4 Japan Uric Acid Drug Market
9.3.5.4.1 Japan Uric Acid Drug Market by Drug Class
9.3.5.4.2 Japan Uric Acid Drug Market by Distribution Channel
9.3.5.5 South Korea Uric Acid Drug Market
9.3.5.5.1 South Korea Uric Acid Drug Market by Drug Class
9.3.5.5.2 South Korea Uric Acid Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Uric Acid Drug Market Overview
9.4.2 Middle East and Africa Uric Acid Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Uric Acid Drug Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Uric Acid Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Uric Acid Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Uric Acid Drug Market
9.4.5.1.1 South Africa Uric Acid Drug Market by Drug Class
9.4.5.1.2 South Africa Uric Acid Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Uric Acid Drug Market
9.4.5.2.1 Saudi Arabia Uric Acid Drug Market by Drug Class
9.4.5.2.2 Saudi Arabia Uric Acid Drug Market by Distribution Channel
9.4.5.3 U.A.E Uric Acid Drug Market
9.4.5.3.1 U.A.E Uric Acid Drug Market by Drug Class
9.4.5.3.2 U.A.E Uric Acid Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Uric Acid Drug Market Overview
9.5.2 South and Central America Uric Acid Drug Market Forecasts and Analysis
9.5.3 South and Central America Uric Acid Drug Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Uric Acid Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Uric Acid Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Uric Acid Drug Market
9.5.5.1.1 Brazil Uric Acid Drug Market by Drug Class
9.5.5.1.2 Brazil Uric Acid Drug Market by Distribution Channel
9.5.5.2 Argentina Uric Acid Drug Market
9.5.5.2.1 Argentina Uric Acid Drug Market by Drug Class
9.5.5.2.2 Argentina Uric Acid Drug Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL URIC ACID DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. URIC ACID DRUG MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TEIJIN PHARMA LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. REGENERON PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO. INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SAVIENT PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MYLAN NV
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HORIZON THERAPEUTICS PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca plc.
2. Boehringer Ingelheim GmbH
3. Teijin Pharma Ltd.
4. Regeneron Pharmaceuticals
5. GlaxoSmithKline plc.
6. Merck & Co. Inc.
7. Novartis AG
8. Savient Pharmaceuticals
9. Mylan NV
10. Horizon Therapeutics plc

TIPRE00012954
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.